ci report ep top opco/street estim
adjust result exclud gain transit client
realiz gain impact amort integration/transact
legal result includ tax benefit beat driven
out-performance across segment led health servic vs opco/
street integr medic vs opco/street
mcr slightli higher opco/street manag
suggest perform line expect adjust
mcr guidanc rais ep guidanc
led integr medic midpoint compani also
re-affirmed ep target follow quarter rais
ep estim
recap servic earn opco/street
integr medic earn opco/street top
expect mcr slightli expect opco/street
due expect pull-back individu busi includ
expressscript updat manag remain bullish expressscript profit
mid-singl digit expect single-digit
furthermor growth continu year-end driven season
synergi in-sourc also estim retent rate
selling-season prior reiter organ
guidanc rais guidanc
second straight quarter rais due integr
medic vs larg driven sg vs prior
improv also despit lower membership growth expect
vs lastli despit mcr tick-up manag maintain
annual outlook cost-trend
earn stress earn would back-half load
due time certain suppli chain initi benefit stronger perform
specialti gener expect ramp synergi off-set anthem
strand cost compani also expect script
in-sourc pbm
conclus overal result strong continu put concern
around esrx acquisit rest given stock attract valuat
believ long-term holder ultim reward result maintain
outperform rate would continu buyer
year price histori ci
provid health care relat
benefit us intern
compani offer insur self-
health vision plan well
disabl life insur product
analyst certif import disclosur see disclosur
portfolio target strong growth market avoid
mani risk driven concentr aso
busi compani also strong track record growth
recent year tradit trade discount
peer although posit neg
express script deal believ highli accret deal
pay strong long-term return sharehold given compel
opportun cross-sel servic mention
equity-friendli capit structur result rate stock
integr includ express script goe expect
guidanc issu updat
integr includ express script goe well
medicar busi growth margin acceler
signific uptick util
integr includ express script goe poorli
disabl life busi continu face volatil
exchang busi turn materi loss
price target base combin two methodolog dcf valuat base beta
termin growth rate wacc estim ebitda price-to-earnings target repres
ep estim conserv discount group current trade compani face
integr risk express script transact uncertain drug regulatori environ
includ healthcar reform federal/st regul chang cost trend intern busi risk
premium fee
healthcar premium
sell gener administr expens
premium fee
pharmaci servic cost elimin
total benefit expens
incom attribut non-controlling interest
dilut ep report
premium fee
sell gener administr expens
total benefit expens
